Interferon for Decreasing the Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

Publisher： Karger

E-ISSN： 1423-0232|62|1|87-93

ISSN： 0030-2414

Source： Oncology, Vol.62, Iss.1, 2002-01, pp. : 87-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 59-63

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years

By  

Intervirology, Vol. 58, Iss. 1, 2015-01 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Influence of Occult Hepatitis B Virus Coinfection on the Incidence of Fibrosis and Hepatocellular Carcinoma in Chronic Hepatitis C

By  

Intervirology, Vol. 51, Iss. 5, 2009-01 ,pp. : 352-361

Karger

Access to resources Recommend Favorite